Sai Life Sciences Ltd.
NSE: SAILIFE
Prev Close
942.9
Open Price
945.95
Volume
562,908
Today Low / High
915.6 / 961.45
52 WK Low / High
636.1 / 983.35
Range
878 - 970
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 923.8, with a change of -19.1 (-2.02567%). The expected target range on the NSE is between 878 - 970. The stock is experiencing a downward trend on the NSE. Investors should be cautious as the price is currently declining.
Sai Life Sciences Ltd. Graph
Sai Life Sciences Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Sai Life Sciences Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 923.80, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 923.80 | 933.04 | 839.73 - 1,026.34 |
| 942.28 | 753.82 - 1,130.73 | ||
| 951.51 | 666.06 - 1,236.97 | ||
| Bearish Scenario | 923.80 | 914.56 | 823.11 - 1,006.02 |
| 905.32 | 724.26 - 1,086.39 | ||
| 896.09 | 627.26 - 1,164.91 |
Overview of Sai Life Sciences Ltd.
ISIN
INE570L01029
Industry
Medical - Diagnostics & Research
Vol.Avg
451,015
Market Cap
195,502,657,726
Last Dividend
0
Official Website
IPO Date
2024-12-18
DCF Diff
1,044.66
DCF
-125
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,695.81 Cr | 1,272.79 Cr | 618.89 Cr | 0.3650 | 0.00 Cr | 35.14 Cr | 273.15 Cr | 170.13 Cr | 8.83 | 442.44 Cr | 0.1003 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 91.12 Cr | 3,159.98 Cr | 1,031.62 Cr | 2,128.3550 Cr | 352.38 Cr | 261.26 Cr | 118.87 Cr | 1,607.80 Cr | 0.00 Cr | 0.00 Cr | 1.96 Cr | 732.4900 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 277.4440 Cr | -552.5760 Cr | 353.9370 Cr | -91.8360 Cr | 186.9490 Cr | 224.7490 Cr | -369.2800 Cr | 227.7030 Cr | -570.4220 Cr | 0.0000 Cr | -31.4220 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 556.46 Cr | 345.01 Cr | 211.45 Cr | 0.3800 | 143.78 Cr | 100.38 Cr | 4.77 | 187.94 Cr | 0.1804 |
| 2025-09-30 | 537.47 Cr | 342.66 Cr | 194.81 Cr | 0.3624 | 106.08 Cr | 83.84 Cr | 4.01 | 161.15 Cr | 0.1560 |
| 2025-06-30 | 496.42 Cr | 301.73 Cr | 194.69 Cr | 0.3922 | 83.21 Cr | 60.46 Cr | 2.90 | 130.84 Cr | 0.1218 |
| 2025-03-31 | 545.33 Cr | 345.43 Cr | 199.90 Cr | 0.3666 | 126.15 Cr | 88.27 Cr | 0.00 | 167.17 Cr | 0.1619 |
| 2024-12-31 | 439.78 Cr | 253.77 Cr | 186.01 Cr | 0.4230 | 85.66 Cr | 53.85 Cr | 2.89 | 128.87 Cr | 0.1225 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 306.22 Cr | 0.00 Cr | 306.22 Cr | 491.99 Cr | 122.23 Cr | 1,489.48 Cr | 1,728.18 Cr | 3,331.51 Cr | 1,061.80 Cr |
| 2025-03-31 | 91.12 Cr | 281.13 Cr | 372.25 Cr | 786.80 Cr | 118.87 Cr | 1,504.51 Cr | 1,607.80 Cr | 3,159.98 Cr | 1,031.62 Cr |
| 2024-09-30 | 49.05 Cr | 163.00 Cr | 212.05 Cr | 619.62 Cr | 105.89 Cr | 1,034.59 Cr | 1,384.20 Cr | 2,476.78 Cr | 1,431.22 Cr |
| 2024-03-31 | 23.66 Cr | 161.00 Cr | 184.66 Cr | 590.05 Cr | 87.44 Cr | 945.11 Cr | 1,275.17 Cr | 2,275.14 Cr | 1,299.99 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial cash flow statement data available. | |||||||||
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Diagnostics & Research
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Dr. Lal PathLabs Limited | LALPATHLAB | ₹1,425.00 | ₹237,937,200,450.00 | ₹99,157.00 |
| Sai Life Sciences Ltd. | SAILIFE | ₹923.80 | ₹195,502,657,726.00 | ₹562,908.00 |
| Vijaya Diagnostic Centre Limited | VIJAYA | ₹990.20 | ₹101,718,235,588.00 | ₹65,440.00 |
| Metropolis Healthcare Limited | METROPOLIS | ₹1,886.40 | ₹97,775,696,160.00 | ₹13,601.00 |
Key Executives
Gender: Not Specified
Year Born:
Gender: Not Specified
Year Born: 1951
Gender: male
Year Born:
Gender: male
Year Born: 1971
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: female
Year Born:
FAQs about Sai Life Sciences Ltd.
The CEO is Krishnam Raju Kanumuri.
The current price is ₹923.80.
The range is ₹636.1-983.35.
The market capitalization is ₹19,550.27 crores.
The P/E ratio is 58.39.
The company operates in the Healthcare sector.
Overview of Sai Life Sciences Ltd. (ISIN: INE570L01029) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹19,550.27 crores and an average daily volume of 451,015 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹0.